Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia Therapeutics jumps on upbeat trial results for pancreatic cancer drug

** Shares of Amplia Therapeutics  ATX.AX  rise as much as
16.3% to A$0.100, posting their biggest percentage gain since
Oct. 10
    ** Stock hits its highest level since Nov. 15
    ** Drug developer reports positive clinical trial results
for its pancreatic cancer drug narmafotinib
    ** Says 35% patients show partial response in trial vs 23%
in historical standard-of-care treatment
    ** About 6.4 mln shares change hands, compared with the
30-day average volume of around 1.6 mln
    ** Stock up 20.7% YTD, including session's move



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com))

Recent news on Amplia Therapeutics

See all news